Results 201 to 210 of about 36,696 (303)

Sulfonylurea treatment in type 2 diabetes.

, 2018
Kirstin Bester, Joey Ton, Christina Korownyk   +2 more
openalex  

Real‐world persistence and dose titration of GLP‐1 receptor agonists in type 2 diabetes: A UK population‐based cohort study by obesity and cardiovascular disease status

Diabetes, Obesity and Metabolism, Volume 28, Issue 4, Page 3386-3395, April 2026.
Abstract Aims Real‐world medication use varies across clinical trial and healthcare settings; therefore, we evaluated GLP‐1 receptor agonist (GLP‐1RA) persistence and dose titration among adults with type 2 diabetes in UK primary care, stratified by agent, obesity status, cardiovascular disease (CVD) history, and sex assigned at birth.
Franziska S. Ulrich, Nicola Napoli, Morten Frost Nielsen, Andrea M. Burden   +3 more
wiley   +1 more source

GLP-1RAs: antidiabetic drug crossover-new hope for chronic inflammatory airway diseases. [PDF]

Respir Res
Chen Y, Shen Y, Shen H, Liu Z.
europepmc   +1 more source

Sulfonylureas in type 2 diabetes mellitus: Current evidence, conflicts and clinical implications

, 2017
ChiedozieKenneth Ugwoke, Urban Slokar, Atsuhito Nakayama, Nejc Umek   +3 more
openalex   +1 more source

Economic Burden of Type 2 Diabetes Mellitus Treatment Strategies: A Cost Consequence Analysis of Sitagliptin vs Sulfonylureas in Lombardy Region [PDF]

, 2015
Stefano Genovese, E Casas-De la Torre, Fabio Baccetti   +2 more
openalex   +1 more source

Safety of anagliptin/metformin combination tablets evaluated by non‐inferiority between pre‐ and post‐serum lactic acid levels in Japanese patients with type 2 diabetes and moderate renal impairment (AMELIO STUDY)

Journal of Diabetes Investigation, Volume 17, Issue 4, Page 636-648, April 2026.
To investigate the safety of anagliptin/metformin combination tablets in Japanese patients of type 2 diabetes with moderate renal impairment. This study demonstrates that the fixed‐dose combination of anagliptin and metformin can be used safely in patients with type 2 diabetes complicated by moderate renal dysfunction.
Hiroshi Kajio, Ryotaro Bouchi, Mitsuhisa Komatsu, Masanori Yamazaki, Daisuke Takarabe, Masahide Okamoto, Takahisa Tanaka, Toru Kitazawa, Hisayuki Katsuyama, Yasumichi Mori, Mitsuhiko Noda   +10 more
wiley   +1 more source

Impact of mistreatment on the learning of novice medical students: An experimental study

Medical Education, Volume 60, Issue 4, Page 453-460, April 2026.
Abstract Introduction Mistreatment toward peers, residents, and patients has been shown to trigger negative emotions among medical trainees. However, the impact of such experiences on trainees' learning needs to be further explored. This study reports on the impact of a situation of mistreatment experienced by a medical resident on novice medical ...
Fernanda Aparecida Tranches Martins, Ligia Maria Cayres Ribeiro, Rita de Cássia Corrêa Miguel, Telma Kremer, Alexandre Sampaio Moura, Silvia Mamede   +5 more
wiley   +1 more source

Opposite kinetics of L-leucine and L-phenylalanine induced insulin release studies with the perfused rat pancreas [PDF]

, 1972
Landgraf, R., Landgraf-Leurs, M. M. C., Schwarz, K., Scriba, Peter Christian   +3 more
core  

Supplementary Figure S3 from Glibenclamide Targets Sulfonylurea Receptor 1 to Inhibit p70S6K Activity and Upregulate KLF4 Expression to Suppress Non-Small Cell Lung Carcinoma

, 2023
Kexin Xu, Geng Sun, Min Li, Hongling Chen, Zuhao Zhang, Xixi Qian, Ping Li, Lin Xu, Wenbin Huang, Xuerong Wang   +9 more
openalex   +1 more source

Two cases (a decade apart) of severe sulfonylurea-positive hypoglycemia associated with inhaled heroin use. [PDF]

JCEM Case Rep
Weisbrot B, Kim KY, Zacharia C, Hwang JL.   +3 more
europepmc   +1 more source